Silver Point Capital »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Silver Point Capital

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Silver Point Capital from 13F filings

Historical chart of Silver Point Capital investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Silver Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Silver Point Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.0M 8.0M 0.88

More positions owned by Silver Point Capital

Gulfport Energy Corp Common Shares (GPOR)
Echostar Corp Note 3.875%11/3 (Principal)
Jd.com Note 0.250% 6/0 (Principal)
Studio City Intl Hldgs Spon Ads (MSC)
Ishares Gold Tr Ishares New (IAU)
Echostar Corp Cl A (SATS)
Ishares Tr Russell 2000 Etf (IWM)
PG&E Corporation (PCG)
Diversified Healthcare Tr Com Sh Ben Int (DHC)
Bausch Plus Lomb Corp Common Shares (BLCO)
Pg&e Corp Pfd Conv Ser A (PCG.PX)
Telephone & Data Sys Com New (TDS)
Edison International (EIX)
Frontier Group Hldgs (ULCC)
Southwest Airlines (LUV)

View all positions for Silver Point Capital

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Balyasny Asset Management
Linden Advisors
Highbridge Capital Management
Oaktree Capital Management
D. E. Shaw & Co
DG Capital Management
Calamos Advisors
Davidson Kempner Capital Management
Agf Management
Readystate Asset Management
LMR Partners
State Street Corporation
Silver Point Capital
Man Group
Capstone Investment Advisors

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1